Technology Listings


Water Soluble Progesterone Analogues for Treatment of Traumatic Brain Injuries

Application

Shelf-stable, water-soluble prodrugs of progesterone oximes for the treatment of traumatic brain injuries (TBI).

Key Benefits
  • Compound has activity equal to native progesterone, but is readily soluble in aqueous based, injectable dose formulations and well suited for use in the clinic and by first responders.
  • Compound has been shown to cross the blood brain barrier (BBB).
Market Summary

In the United States, an estimated 1.7 million people suffer a traumatic brain injury (TBI) and 52,000 result in deaths annually. Several compounds are being investigated for the treatment of acute TBI, but there is currently no approved pharmacological treatment for TBI. Maintenance of TBI is aimed at minimizing or preventing secondary injury due to TBI and rehabilitation. Progesterone, present in the brains of men and women, has the potential for dramatically improved patient outcome following head trauma.

Technical Summary

Researchers at Emory University have shown that progesterone oximes reduce brain edema and functional impairments in rat models of traumatic brain injury and stroke. A series of prodrug derivatives of these oximes have been identified that are sufficiently water soluble and stable in solution to allow for facile formulation for intramuscular or intravenous administration. Pharmacokinetic studies show that the prodrugs are rapidly cleaved in vivo to generate high levels of the active oxime in plasma and in brain tissue. This technology is therefore suitable for use by both first responders and physicians to allow for rapid administration to patients with TBI or stroke.

Developmental Stage
  • Lead compound has been identified.
  • In vivo studies have been completed in appropriate animal models.
Patent Information
App Type Country Serial No. Patent No. File Date Issued Date Expire Date
Nationalized PCT - United States United States 14/911,807 8/11/2014    
Nationalized PCT - Foreign EP 14835820.3   8/11/2014    
Tech ID: 13138
Published: 6/24/2016
Category
Therapeutics

Contact
Justin Burns
Licensing Associate
Emory University
justin.burns@emory.edu

Inventor(s)
Dennis Liotta
Iqbal Sayeed
Donald Stein
David Guthrie
Mark Lockwood
Michael Natchus

Keywords
Neuroscience/Pain